hormone optimization

Biote Acquires Asteria Health for $8.5M, Names New CFO

by | Jan 24, 2024
"This strategic transaction expands and strengthens Biote’s capabilities by enabling the vertical integration of our manufacturing and providing direct control over our pharmacokinetic research efforts," Biote CEO Terry Weber said. Earlier this month, Robert Peterson was named as Biote's new CFO.
Biote Enlists Healthcare Veteran to Drive Men’s Hormone Therapy Expansion
by | Apr 14, 2023

Irving-based Biote Corporation, a preventive healthcare solutions provider that delivers personalized hormone therapy, has appointed John Denne as general manager of its men’s health division. The move is aimed at expanding the company’s presence in the growing market for male hormone replacement therapy....

Irving-Based Biote to Be Listed on Nasdaq
Irving-based Biote, a medical practice-building business within the hormone optimization space, will be listed on Nasdaq through a business combination with Haymaker Acquisition Corp. III.

Biote—which will earn projected revenue of $136 million in 2021—trains practitioners to identify and treat early indicators of hormone-related aging conditions. The company then provides components that enable practitioners to establish, build, and successfully operate hormone optimization centers.